4UP-27714-46535
3 vaccinations
3 coded responses
9 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 070 / NJ
- Registered
- 2021-10-12
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-28
Dose 2 — Pfizer-BioNTech
-
2021-10-08
Dose 3 — Pfizer-BioNTech
-
2021-10-12
Registered in v-safe
-
2021-10-12
Survey response — days 1–6 daily, dose 3MedDRA: Oral herpes — Feeling: Fair · Site: Pain, Redness, SwellingFree text: Cold soreMedDRA releases: 2024-11 · check-in free text available
-
2021-10-14
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Itching · NoneAdult check-in
- 2021-10-15
- 2021-10-31
- 2021-11-05
-
2021-11-12
Survey response — day 35, dose 3MedDRA: Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend schoolFree text: Upper respiratory infectionMedDRA releases: 2024-11 · check-in free text available
- 2022-01-07
-
2022-04-10
Survey response — 6 months, dose 3MedDRA: Ageusia, COVID-19, Chills, Pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid, chills, lost of taste, body achesMedDRA releases: 2024-11 · check-in free text available
-
2022-04-10
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-04-13
- 2022-10-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | No |
| 2 | 2021-01-28 | Pfizer-BioNTech | No |
| 3 | 2021-10-08 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-10 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Cold sore
Release 10 — day 35, dose 3
Symptoms: Upper respiratory infection
Release 11 — 6 months, dose 3
Symptoms: Covid, chills, lost of taste, body aches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Oral herpes | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release